Cytokinetics (CYTK) Payables (2016 - 2025)
Historic Payables for Cytokinetics (CYTK) over the last 16 years, with Q3 2024 value amounting to $11.6 million.
- Cytokinetics' Payables fell 1605.54% to $11.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $11.6 million, marking a year-over-year decrease of 1605.54%. This contributed to the annual value of $21.5 million for FY2023, which is 1602.44% down from last year.
- According to the latest figures from Q3 2024, Cytokinetics' Payables is $11.6 million, which was down 1605.54% from $9.5 million recorded in Q2 2024.
- Cytokinetics' Payables' 5-year high stood at $25.6 million during Q4 2022, with a 5-year trough of $2.9 million in Q2 2020.
- Over the past 5 years, Cytokinetics' median Payables value was $13.8 million (recorded in 2023), while the average stood at $13.4 million.
- As far as peak fluctuations go, Cytokinetics' Payables crashed by 4378.13% in 2020, and later soared by 41123.29% in 2021.
- Over the past 5 years, Cytokinetics' Payables (Quarter) stood at $8.0 million in 2020, then soared by 161.95% to $21.1 million in 2021, then rose by 21.45% to $25.6 million in 2022, then fell by 16.02% to $21.5 million in 2023, then plummeted by 46.15% to $11.6 million in 2024.
- Its Payables was $11.6 million in Q3 2024, compared to $9.5 million in Q2 2024 and $13.0 million in Q1 2024.